DVAX logo

Dynavax Technologies (DVAX)

Profile

Full Name

Dynavax Technologies Corporation

Ticker Symbol

DVAX

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

February 19, 2004

Indexes

Not included

Website

http://www.dynavax.com

Employees

405

Key Details

Price

$10.27(+1.08%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$277.25M(+19.36% YoY)

Annual EPS

$0.20(+500.00% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $10.27
    DVAX price is $10.27

    30-Day Relative Volume

    0.29
    DVAX 30-day relative volume is 0.29

    Price Performance

    Price Most recent change

    +1.08%
    DVAX price was up +1.08% on Jul 3, 2025

    Price YTD change

    -19.58%
    DVAX price is down -19.58% since January 1st

    Price 1-year change

    -6.81%
    DVAX price is down -6.81% year-on-year

    Price 3-year change

    -20.76%
    DVAX price is down -20.76% over the past 3 years

    Price Range

    Price All-time high

    $106.60
    DVAX price is currently -90.37% below its historical high of $106.60

    Price 3-year low

    $9.22
    DVAX price is currently +11.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.23B
    DVAX market capitalization is $1.23 billion

    Market cap 3-year change

    -24.74%
    DVAX market capitalization is down -24.74% over the past 3 years

    Market cap All-time high

    $2.51B
    DVAX market capitalization is currently -50.90% below its historical high of $2.51 billion

    Market cap sector rank

    77.74%
    DVAX market capitalization is higher than 77.74% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -8.32%
    DVAX shares outstanding is down -8.32% year-on-year

    Shares Outstanding 3-Year Change

    -5.03%
    DVAX shares outstanding is down -5.03% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.54
    DVAX beta is 0.54

    200-day SMA

    $11.87
    DVAX price is currently -13.48% below its 200-day simple moving average

    50-day SMA

    $10.19
    DVAX price is currently +0.83% above its 50-day simple moving average

    RSI

    54.20
    DVAX 14-day relative strength index is 54.20

    Volume

    0.29
    DVAX 30-day relative volume is 0.29

    ATR

    $0.35
    DVAX average true range is $0.35

    10-day Historical Volatility

    24.30%
    DVAX 10-day historical volatility is 24.30%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $277.25M
    DVAX annual revenue is $277.25 million

    Revenue Analysts estimate

    $332.75M
    DVAX annual revenue is currently -16.68% lower than the consensus analysts' forecast

    Revenue 1-year change

    +19.36%
    DVAX annual revenue is up +19.36% year-on-year

    Revenue Sector rank

    67.68%
    DVAX annual revenue is higher than 67.68% of companies in Healthcare sector

    EPS

    EPS

    $0.20
    DVAX annual earnings per share is $0.20

    EPS Analysts estimate

    -$0.42
    DVAX annual earnings per share is currently -147.62% lower than the consensus analysts' forecast

    EPS 1-year change

    +500%
    DVAX annual earnings per share is up +500% year-on-year

    EPS Sector rank

    85.01%
    DVAX annual earnings per share is higher than 85.01% of companies in Healthcare sector

    Profit

    Gross profit

    $227.80M
    DVAX annual gross profit is $227.80 million

    Gross margin

    82.17%
    DVAX annual gross profit margin is 82.17%

    Operating profit

    -$4.12M
    DVAX annual operating income is -$4.12 million

    Operating margin

    -1.49%
    DVAX annual operating profit margin is -1.49%

    Net income

    $27.31M
    DVAX annual net profit is $27.31 million

    Net margin

    9.85%
    DVAX annual net profit margin is 9.85%

    Expenses

    Total expenses

    $281.37M
    DVAX annual total expenses is $281.37 million

    Operating expenses

    $231.92M
    DVAX annual total operating expenses is $231.92 million

    Cost of goods sold

    $49.45M
    DVAX annual cost of goods sold is $49.45 million

    Selling, general & administrative expenses

    $170.37M
    DVAX annual SGA is $170.37 million

    Depreciation and amortization

    $8.05M
    DVAX annual depreciation & amortization is $8.05 million

    Interest expense

    $6.79M
    DVAX annual interest expense is $6.79 million

    Income tax

    $3.55M
    DVAX annual income tax is $3.55 million

    EBIT & EBITDA

    EBIT

    $37.65M
    DVAX annual earnings before interest & taxes is $37.65 million

    EBITDA

    $45.70M
    DVAX annual EBITDA is $45.70 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $986.26M
    DVAX annual total assets is $986.26 million

    Non current assets

    $137.31M
    DVAX annual long term assets is $137.31 million

    Current assets

    $848.94M
    DVAX annual total current assets is $848.94 million

    Cash and cash equivalents

    $95.88M
    DVAX annual cash & cash equivalents is $95.88 million

    Accounts receivable

    $45.28M
    DVAX annual accounts receivable is $45.28 million

    Inventory

    $70.05M
    DVAX annual inventory is $70.05 million

    Liabilities

    Total liabilities

    $389.46M
    DVAX annual total liabilities is $389.46 million

    Long term liabilities

    $310.82M
    DVAX annual total long term liabilities is $310.82 million

    Current liabilities

    $78.63M
    DVAX annual total current liabilities is $78.63 million

    Accounts payable

    $9.06M
    DVAX annual accounts payable is $9.06 million

    Debt

    Total debt

    $254.42M
    DVAX annual total debt is $254.42 million

    Total debt 1-year change

    -0.97%
    DVAX annual total debt is down -0.97% year-on-year

    Long term debt

    $250.24M
    DVAX annual long term debt is $250.24 million

    Short term debt

    $4.17M
    DVAX annual short term debt is $4.17 million

    Equity & Capital

    Shareholders equity

    $596.80M
    DVAX annual stockholders equity is $596.80 million

    Book value

    $596.80M
    DVAX annual book value is $596.80 million

    Retained earnings

    -$903.27M
    DVAX annual retained earnings is -$903.27 million

    Working capital

    $770.31M
    DVAX annual working capital is $770.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $66.51M
    DVAX annual cash flow from operations is $66.51 million

    Cash from operations 1-year change

    -33.86%
    DVAX annual cash flow from operations is down -33.86% year-on-year

    Cash from investing

    -$18.04M
    DVAX annual cash flow from investing activities is -$18.04 million

    Cash from investing 1-year change

    +88.28%
    DVAX annual cash flow from investing activities is up +88.28% year-on-year

    Cash from financing

    -$102.02M
    DVAX annual cash flow from financing activities is -$102.02 million

    Cash from financing 1-year change

    -7460.53%
    DVAX annual cash flow from financing activities is down -7460.53% year-on-year

    CAPEX

    CAPEX

    $6.35M
    DVAX annual capital expenditures is $6.35 million

    CAPEX 1-year change

    +54.78%
    DVAX annual capital expenditures is up +54.78% year-on-year

    Free Cash Flow

    Free cash flow

    $60.16M
    DVAX annual free cash flow is $60.16 million

    Free cash flow 1-year change

    -37.63%
    DVAX annual free cash flow is down -37.63% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    82.17%
    DVAX annual gross profit margin is 82.17%

    Operating margin

    -1.49%
    DVAX annual operating profit margin is -1.49%

    Net margin

    9.85%
    DVAX annual net profit margin is 9.85%

    ROA & ROE

    ROA

    2.75%
    DVAX annual return on assets is 2.75%

    ROE

    4.48%
    DVAX annual return on equity is 4.48%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DVAX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DVAX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.32
    DVAX price to book ratio is 2.32

    PB ratio Sector rank

    61.34%
    DVAX price to book ratio is higher than 61.34% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.19
    DVAX price to sales ratio is 4.19

    PS ratio Sector rank

    58.6%
    DVAX price to sales ratio is higher than 58.6% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.47B
    DVAX enterprise value is $1.47 billion

    Enterprise value Sector rank

    77.89%
    DVAX enterprise value is higher than 77.89% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -36.15
    DVAX EV/EBITDA is -36.15

    EV/EBITDA Sector rank

    4.97%
    DVAX EV/EBITDA is higher than 4.97% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.80
    DVAX annual current ratio is 10.80

    Quick ratio

    9.91
    DVAX annual quick ratio is 9.91

    Leverage

    Debt to equity

    0.38
    DVAX annual debt to equity ratio is 0.38

    Interest coverage ratio

    5.54
    DVAX annual interest coverage ratio is 5.54

    Risk & Stability

    Piotroski F-Score

    5
    DVAX piotroski f-score is 5

    Altman Z-Score

    1.96
    DVAX altman z-score is 1.96

    Analyst ratings

    Recent major analysts updates

    May 7, 25 JMP Securities
    Market Outperform
    Apr 17, 25 Goldman Sachs
    Sell
    Feb 21, 25 HC Wainwright & Co.
    Buy
    Feb 21, 25 Citizens Capital Markets
    Market Outperform
    Feb 11, 25 Goldman Sachs
    Sell
    Jan 14, 25 HC Wainwright & Co.
    Buy
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Oct 15, 24 HC Wainwright & Co.
    Buy
    Aug 8, 24 Goldman Sachs
    Neutral
    Aug 7, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with DVAX included

    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Companies with buyback
    • What is the ticker symbol for Dynavax Technologies?
    • Does Dynavax Technologies pay dividends?
    • What sector is Dynavax Technologies in?
    • What industry is Dynavax Technologies in?
    • What country is Dynavax Technologies based in?
    • When did Dynavax Technologies go public?
    • Is Dynavax Technologies in the S&P 500?
    • Is Dynavax Technologies in the NASDAQ 100?
    • Is Dynavax Technologies in the Dow Jones?
    • When was Dynavax Technologies's last earnings report?
    • When does Dynavax Technologies report earnings?
    • Should I buy Dynavax Technologies stock now?

    What is the ticker symbol for Dynavax Technologies?

    The ticker symbol for Dynavax Technologies is NASDAQ:DVAX

    Does Dynavax Technologies pay dividends?

    No, Dynavax Technologies does not pay dividends

    What sector is Dynavax Technologies in?

    Dynavax Technologies is in the Healthcare sector

    What industry is Dynavax Technologies in?

    Dynavax Technologies is in the Drug Manufacturers - Specialty & Generic industry

    What country is Dynavax Technologies based in?

    Dynavax Technologies is headquartered in United States

    When did Dynavax Technologies go public?

    Dynavax Technologies's initial public offering (IPO) was on February 19, 2004

    Is Dynavax Technologies in the S&P 500?

    No, Dynavax Technologies is not included in the S&P 500 index

    Is Dynavax Technologies in the NASDAQ 100?

    No, Dynavax Technologies is not included in the NASDAQ 100 index

    Is Dynavax Technologies in the Dow Jones?

    No, Dynavax Technologies is not included in the Dow Jones index

    When was Dynavax Technologies's last earnings report?

    Dynavax Technologies's most recent earnings report was on May 6, 2025

    When does Dynavax Technologies report earnings?

    The next expected earnings date for Dynavax Technologies is Aug 6, 2025

    Should I buy Dynavax Technologies stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page